BTK and B-cell chronic lymphocytic leukemia: The patient was started on Zanubrutinib, a Bruton tyrosine kinase inhibitor (BTKi), with stabilization of renal function.<h4>Conclusion</h4>This case highlights a rare and clinically significant presentation of CLL involving a renal allograft.